Your browser doesn't support javascript.
loading
Pharmacological characterization of the interaction between tiotropium and olodaterol administered at 5:5 concentration-ratio in equine bronchi.
Calzetta, Luigino; Rogliani, Paola; Mattei, Maurizio; Alfonsi, Pietro; Cito, Giuseppe; Pistocchini, Elena; Cazzola, Mario; Matera, Maria Gabriella.
Afiliação
  • Calzetta L; a Department of Systems Medicine , University of Rome Tor Vergata , Rome , Italy.
  • Rogliani P; a Department of Systems Medicine , University of Rome Tor Vergata , Rome , Italy.
  • Mattei M; b Department of Biology, Centro Servizi Interdipartimentale-STA , University of Rome Tor Vergata , Rome , Italy.
  • Alfonsi P; c ASL Roma 2, UOC Igiene degli Allevamenti e delle Produzioni Zootecniche , Rome , Italy.
  • Cito G; d ASL Roma 2, UOC Tutela igienico sanitaria degli alimenti di origine animale , Rome , Italy.
  • Pistocchini E; e CDVet, Laboratorio Analisi Veterinarie , Rome , Italy.
  • Cazzola M; a Department of Systems Medicine , University of Rome Tor Vergata , Rome , Italy.
  • Matera MG; f Department of Experimental Medicine , University of Campania Luigi Vanvitelli , Naples , Italy.
COPD ; 14(5): 526-532, 2017 Oct.
Article em En | MEDLINE | ID: mdl-28745522
ABSTRACT
Equine airways represent a suitable ex vivo model to study the functional impact of pharmacological treatments on human chronic obstructive pulmonary disorders, such as asthma and chronic obstructive pulmonary disease (COPD). We aimed to characterize the pharmacological interaction between the long-acting muscarinic antagonist (LAMA) tiotropium and the long-acting ß2-agonist (LABA) olodaterol in equine airways. The effect of tiotropium and olodaterol, administered alone and in combination at the ratio of concentrations reproducing ex vivo the concentration-ratio delivered by the currently available fixed-dose combination (FDC) (55), was investigated on the cholinergic contractile tone induced by the parasympathetic activation of equine isolated airways. The drug interaction was analysed by using the Bliss Independence and Unified Theory models. Both tiotropium and olodaterol induced a sub-maximal concentration-dependent inhibition of bronchial contractility (Emax tiotropium 83.6 ± 14.8%, olodaterol 76.9 ± 17.9%; pEC50 tiotropium 8.2 ± 0.5; olodaterol 8.3 ± 0.6). When administered at 55 concentration-ratio, tiotropium plus olodaterol completely inhibited the bronchial contractility (Emax 102.7 ± 8.4%; pEC50 9.0 ± 0.7). Strong synergistic interaction was detected for tiotropium/olodaterol combination (combination index 0.011). When administered at low concentrations, the drug mixture elicited up to 94.6 ± 9.5% effect that was 36.0 ± 8.1% greater than the expected additive effect. The results of this study demonstrate that the co-administration of tiotropium plus olodaterol at 55 concentration-ratio leads to synergistic inhibition of equine bronchial contractility when compared with either drug administered alone. These findings suggest that the currently available LABA/LABA FDC may be effective in delivering tiotropium/olodaterol combination at equipotency concentrations of each monocomponent into the lung and, thus, inducing synergistic effect in the airways.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Brônquios / Broncodilatadores / Benzoxazinas / Brometo de Tiotrópio Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: COPD Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Brônquios / Broncodilatadores / Benzoxazinas / Brometo de Tiotrópio Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: COPD Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Itália